In the first study of its kind, a team of researchers in Canada examined marijuana (cannabis) use and the risk of suicidal behavior in psychiatric populations rather than the general population to see if similar results would be found (i.e., marijuana use increases suicidal behaviors). What they found could be used to inform the medical community working with these psychiatric populations in their assessment of suicide risk.
Monthly Archives: July 2018
Where is your fat accumulating? Different fat distribution is linked to different cardiometabolic risk in a sex-dependent manner
Differences in body compositions between men and women are unravelled in this recent publication in Biology of Sex Differences. Taking advantage of modern anatomic and functional imaging techniques, the authors shine a light on subtle differences of fat distribution, and associate them with different metabolic risk amongst sexes.
Treating patients with malaria first requires a confirmed diagnosis. It has recently come to light that not all diagnosis tests are equal, and some tests, including rapid diagnostic tests (RDTs), can potentially show false positive results in certain patient populations. The following study explores the accuracy of different malaria RDTs that recognize specific malaria antigens.
In this blog Margot Puerta reports on the Bioelectronic Medicine: Technology Targeting Molecular Mechanisms symposium which took place in June. This three-day meeting had the aim of developing the field of bioelectronic medicine and brought together leading scientists and industry leaders from around the globe.
Continued technical developments in genome engineering have recently allowed the generation of conditional mouse models using long DNA templates. Lydia Teboul, author of a new study in BMC Biology, explains how these long templates can also be used to create point mutations away from the target site, but additional unwanted modifications render the validation of new mutants essential.
On July 26th – July 29th the 33rd international conference of Alzheimer’s Disease International (ADI) will be descending on Chicago. This blog gives you a flavor of the interesting research and information that you will be able to find at the conference. BMC will be attending the conference so please find come and find us to hear more about the exciting work we are undertaking.
Assessing cognition in patients with early Alzheimer’s disease – an experts views on the new FDA guidance
A recent commentary published in Alzheimer’s Research and Therapy highlights the benefits and flaws of the new FDA guidelines for Alzheimer’s drug development. In this blog John Harrison, an associate professor at the Alzheimer Center at the VU Medical Center in Amsterdam, sheds some light on the new FDA guidelines and what this means for the future of Alzheimer’s drug development.